Skip to content
PICO Portalanswers from OpenAlex

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma

PaperCitations, authors & open-access status

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma have?

PICO Portalcitation count

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma has 94 citations in the OpenAlex counts PICO Portal stores.

When was Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma published?

PICO Portalyear

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma has 2011 year in the PICO Portal index.

What is the open-access status of Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma?

PICO Portaloa status

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma has closed oa status in the PICO Portal index.

What is the DOI of Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma?

PICO Portaldoi

The DOI for Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma is on the source record.

What is the PMID of Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma?

PICO Portalpmid

The PMID for Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma is on the source record.

What is the OpenAlex record for Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma?

PICO Portalopenalex

The OpenAlex for Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial